Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge.
about
Influenza virus antigenic variation, host antibody production and new approach to control epidemicsPre-existing immunity against swine-origin H1N1 influenza viruses in the general human populationProtective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunizationHeterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza VaccinesBalancing Immune Protection and Immune Pathology by CD8(+) T-Cell Responses to Influenza InfectionMechanisms of Cross-protection by Influenza Virus M2-based VaccinesHost Immunological Factors Enhancing Mortality of Young Adults during the 1918 Influenza PandemicPolarizing T and B Cell Responses by APC-Targeted Subunit VaccinesUniversal immunity to influenza must outwit immune evasionUse of praziquantel as an adjuvant enhances protection and Tc-17 responses to killed H5N1 virus vaccine in miceTumor Progression Locus 2 Promotes Induction of IFNλ, Interferon Stimulated Genes and Antigen-Specific CD8+ T Cell Responses and Protects against Influenza VirusPreemptive priming readily overcomes structure-based mechanisms of virus escapePreexisting CD8+ T-cell immunity to the H7N9 influenza A virus varies across ethnicitiesHLA class I binding 9mer peptides from influenza A virus induce CD4 T cell responsesOseltamivir Prophylaxis Reduces Inflammation and Facilitates Establishment of Cross-Strain Protective T Cell Memory to Influenza VirusesImmunogenicity of HLA Class I and II Double Restricted Influenza A-Derived PeptidesContrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virusIncomplete CD8(+) T lymphocyte differentiation as a mechanism for subdominant cytotoxic T lymphocyte responses to a viral antigenCell-mediated protection in influenza infection.One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge.Pretreatment of epithelial cells with live Streptococcus pneumoniae has no detectable effect on influenza A virus replication in vitroImmunophenotype expressions and cytokine profiles of influenza A H1N1 virus infection in pediatric patients in 2009.The effector T cell response to influenza infectionSuperior in vitro stimulation of human CD8+ T-cells by whole virus versus split virus influenza vaccines.Cellular and humoral cross-immunity against two H3N2v influenza strains in presumably unexposed healthy and HIV-infected subjects.Diverse heterologous primary infections radically alter immunodominance hierarchies and clinical outcomes following H7N9 influenza challenge in miceCombined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity.Fish oil-fed mice have impaired resistance to influenza infection.Protective memory responses are modulated by priming events prior to challenge.Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells.Structural and Biochemical Analyses of Swine Major Histocompatibility Complex Class I Complexes and Prediction of the Epitope Map of Important Influenza A Virus Strains.Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus.A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell ResponsesRIG-I Signaling Is Critical for Efficient Polyfunctional T Cell Responses during Influenza Virus InfectionMemory CD4 T cells direct protective responses to influenza virus in the lungs through helper-independent mechanisms.Exploiting cross-priming to generate protective CD8 T-cell immunity rapidly.Viral replication rate regulates clinical outcome and CD8 T cell responses during highly pathogenic H5N1 influenza virus infection in miceNon-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease.Eosinophils Promote Antiviral Immunity in Mice Infected with Influenza A VirusDynamic variations in the peripheral blood lymphocyte subgroups of patients with 2009 pandemic H1N1 swine-origin influenza A virus infection
P2860
Q21245119-753F77F2-B8C9-4EFC-B208-878D55850708Q24655857-31017043-444B-4445-BDF2-5FFCECA3E59EQ24676991-678D1680-8BE7-47C6-8734-36BCEBEA6BDDQ26744622-184130F6-3B84-4E5A-8272-8303C669DE3EQ26767517-7C102CFE-0575-4F31-8D98-338A88B27E90Q26777740-264CC15A-3A22-4453-AA77-6F0464BD4E1FQ26782795-BB088A10-D387-4C38-9C81-299B57A4A5F7Q26800145-94391F7E-43C9-443C-8897-996E879651EFQ26991896-E214F8B9-5C2C-4A73-9699-3B4B40CDC44DQ27304934-416C7053-914F-4AF4-8359-A820ECE56C0EQ27318631-007FA82D-0438-44D0-83BA-C8F2D615826CQ27676834-4B2DEA78-0D52-478C-A679-636D3AD7FB19Q27681214-AC59D4D1-CF41-49B2-BDDB-631B0027C178Q28473871-8F7161DA-AC88-42FA-BA6A-CC9D83B981D8Q28548477-2FE8B79E-D55B-46E8-83F2-DF3012FE2D48Q28552077-9A27D3C4-4AD6-49B8-BB52-248150C2D89FQ28589623-07C61DCF-006C-433D-BE3E-A7EE1FC7EF29Q30305658-95D31A9B-58E2-481C-BD90-A3105077C51DQ30353071-59C936EC-444C-4638-9F97-2D8A42B73832Q30355863-F82C11B4-34FB-47B1-9FD0-7947C7BCB71BQ30359779-BD4909C6-431C-4453-BCF1-9D6616132619Q30360949-3A80FB6F-66AF-4354-8B0A-48DEB9E657AAQ30361773-F7730C02-D472-4056-9C2B-9E23A358C67AQ30365243-D5169828-4873-402D-ACAC-EB1563A26ABAQ30366119-C69F858D-AE37-4B7E-B570-7AA621129C37Q30371622-BA5B9509-5573-40F3-A199-76E435CFE59DQ30374900-B32024BA-8179-480E-9F4E-7BE6E8FAB145Q30378375-182AEDBC-984B-4E76-8EF4-F212458B0973Q30382279-854FF0A8-3E5D-4CCF-AF35-11FC990226E8Q30382787-FC54C755-CE89-4DF0-9783-3D4AD8A2BC64Q30388011-AE9DAD2A-A70C-4FD2-8A13-C7CD0D51E69BQ30388401-23D31511-6742-4E9C-8338-857C8CF76F88Q30388522-34C4C692-F7AB-4C24-9C06-15CD9A6E26B5Q30390782-EDB0FD6A-91C6-4ED2-977D-93ED76DC63C1Q30390932-662D882E-EA64-45CF-93F9-766D8167A6EAQ30391225-A5EA1E1E-D57C-4DC3-9CD5-49D23FF801BCQ30394897-B7AA8AD0-FCE5-46D3-93DC-A62DCF8EB127Q30395259-D26FEAA5-C4B1-42D1-A4CB-7B65FA14B267Q30399806-BF1C5242-47CE-4B6C-91FB-E22CB2C738CCQ30402640-EAF81FA7-B3DA-4E0A-B317-D948D4341EF1
P2860
Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Transgenic mice lacking class ...... ter influenza virus challenge.
@ast
Transgenic mice lacking class ...... ter influenza virus challenge.
@en
type
label
Transgenic mice lacking class ...... ter influenza virus challenge.
@ast
Transgenic mice lacking class ...... ter influenza virus challenge.
@en
prefLabel
Transgenic mice lacking class ...... ter influenza virus challenge.
@ast
Transgenic mice lacking class ...... ter influenza virus challenge.
@en
P2093
P2860
P356
P1476
Transgenic mice lacking class ...... ter influenza virus challenge.
@en
P2093
P2860
P304
P356
10.1084/JEM.175.4.1143
P407
P577
1992-04-01T00:00:00Z